Dr. Stacey Kalovidouris is the Executive Director of Health-Related Research and Educational Initiatives in the Office of the Advisor to the Provost. She is also the Rice’s Institute of Biosciences and Bioengineering (IBB) Special Projects Director. For IBB, she administers the NIH T32 Cancer Nanotechnology Program between M.D. Anderson Cancer Center and Rice University and she also organizes Rice’s UNIV 594, Responsible Conduct of Research Course. In general, Dr. Kalovidouris facilitates health-related cross-disciplinary research and education, fosters ties with the Texas Medical Center, creates partnerships with industry and promotes the translation of health-related research.
She brings 19 years of experience working at the forefront of early stage scientific advances and discoveries. Recently, she completed the prestigious Kauffman Fellows Program, Class 19. Dr. Kalovidouris is an inventor on a patent for a carbohydrate-protein method of inducing neuronal growth and has published research papers in the diverse areas of nanotechnology, glycobiology, immunology, neuroscience, and drug delivery of cancer therapeutics.
Prior to her current positions, Dr. Kalovidouris was the Executive Director of IBB and she also was a Senior Scientist for Calando Pharmaceuticals, a biopharmaceutical company providing targeted therapeutics for the development of nanoparticle drug formulations. Dr. Kalovidouris completed her post-doctoral training at the California Institute of Technology and holds a PhD in Chemistry from the University of California at Los Angeles, where she was trained by the 2016 Nobel Laureate in Chemistry, Sir J Fraser Stoddart. She received her BA degree in Biochemistry from Swarthmore College.